Skip to main content
. 2016 Jul 15;2(3):FSO135. doi: 10.4155/fsoa-2016-0030

Figure 3. . Effect of type of emulsifier on oral bioavailability of lovastatin.

Figure 3. 

(A) Mean plasma concentration of lovastatin–time curves after oral administration of lovastatin to rats at a dose of 100 mg/kg from a control solution and nanostructured lipid carriers (NLC)s with M3, and S3. (B) Bioluminescence imaging of representative animals at 10 min following oral administration of sulforhodamine B in a control solution, NLCs with M3 and NLCs with S3 (left to right).

M3: Myversol; S3: Soyabean phosphotidyl choline.

Reproduced with permission from [19] © Elsevier (2010).